ph cl 28a has been researched along with 6-ketoprostaglandin f1 alpha in 2 studies
| Studies (ph cl 28a) | Trials (ph cl 28a) | Recent Studies (post-2010) (ph cl 28a) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 4,832 | 294 | 150 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhle, YS; Pankhania, JJ | 1 |
| Antunes, E; Bakhle, YS; De Nucci, G; Hyslop, S; Santana, AC | 1 |
2 other study(ies) available for ph cl 28a and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Treatment in vivo with Ph CL28A alters prostaglandin E2, prostacyclin and leukotriene C4 metabolism in rat isolated lung.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Azo Compounds; Calcimycin; Dinoprostone; Epoprostenol; Hydroxyprostaglandin Dehydrogenases; In Vitro Techniques; Lung; Male; Radioimmunoassay; Rats; Rats, Inbred Strains; SRS-A | 1990 |
Anti-inflammatory activities of Ph CL28A in rats in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azo Compounds; Blood Pressure; Carrageenan; Edema; Epoprostenol; Hydroxyprostaglandin Dehydrogenases; Indomethacin; Leukotriene B4; Male; Pleurisy; Radioimmunoassay; Rats; Rats, Wistar; Thromboxane B2 | 1993 |